일본과 해외의 조사회사나 출판사로부터 출판된 산업 조사 보고서 및 데이터 판매 · 연간 서비스 · 맞춤 정보 제공 ChosaReport-Korea 주식회사 SEMABIZ

헬스케어 시장의 인공지능(AI) – 2030년까지의 세계 예측

Artificial Intelligence (Al) in Healthcare Market – Global Forecast to 2030

헬스케어 시장의 인공지능(AI) – 제공내용(통합), 기능(진단, 게놈, 정밀의료, 방사선, 면역요법, 약국, 공급망), 용도(임상), 최종 사용자(병원), 지역별 – 2030년까지의 세계 예측

Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Immunotherapy, Pharmacy, Supply Chain), Application (Clinical), End User (Hospitals), Region- Global Forecast to 2030

조사회사 MarketsandMarkets
출판년월 2024년12월
페이지 수 738
도표 수 943
라이센스 Single User License
가격 USD 4,950
구성 영문조사보고서

    주문/문의    조사회사/라이센스/납기안내

Report Overview

The global Artificial Intelligence (AI) in healthcare market is projected to reach USD 164.16 billion by 2030 from USD 14.92 billion in 2024, at a CAGR of 49.1% during the forecast period.

헬스케어 시장의 세계 인공지능(AI) 시장은 2024년 149억 2000만 달러에서 2030년까지 1,641억 6000만 달러에 이를 것으로 예측되며, 예측 기간 중 CAGR은 49.1%입니다.

The market is expected to grow as a result of the increasing investments & funding by public-private organizations, the rapid proliferation of AI in the healthcare industry, and the increasing focus on developing human-aware AI systems. Moreover, the market has experienced growth due to rising demand for enhanced services due to a disproportionate ratio between the healthcare workforce and patient numbers. However, insufficient IT infrastructure, and reluctance towards adoption of AI-based healthcare solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

헬스케어 시장의 인공지능(AI) - 2030년까지의 세계 예측
artificial-intelligence-healthcare-market-Overview

“Cloud-based segment is expected to register highest growth during the forecast period, by deployment.”

The Artificial Intelligence (AI) in healthcare software segment is segmented into on-premise, cloud-based, and hybrid model. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment’s growth.

“Hospitals & Clinics dominated the market in the Artificial Intelligence (AI) in healthcare market for healthcare providers, by end user in 2023.”’

The hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers make up the healthcare providers segment of the end user of the Artificial Intelligence (AI) in healthcare market. In 2023, the hospitals & clinics accounted for a significant share of the Artificial Intelligence (AI) in healthcare market, by end user. The prominent position of this segment is due to the push for personalized medicine, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. AI applications, such as clinical decision support systems, predictive analytics for patient outcomes, and automated administrative workflows, address critical challenges like workforce shortages and rising patient loads. Additionally, advancements in medical imaging, integration with EHR systems, and government support for AI-driven healthcare transformation further encourage adoption.

“Asia Pacific is expected to register highest market growth during the forecast period.”

The Artificial Intelligence (AI) in healthcare market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register the highest growth during the forecast period. The high growth of this region is attributed to the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across the healthcare industry and a significant focus on integrating sophisticated technologies across the workflows also contribute to the growth.

헬스케어 시장의 인공지능(AI) - 2030년까지의 세계 예측 region
artificial-intelligence-healthcare-market-Region

The break-down of primary participants is as mentioned below:

  • By Company Type – Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation – Directors: 30%, Manager: 34%, and Others: 36%
  • By Region – North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

  • Koninklijke Philips N.V. (Netherlands)
  • Microsoft (US)
  • Siemens Healthineers AG (Germany)
  • NVIDIA Corporation (US)
  • Epic Systems Corporation (US)
  • GE Healthcare (US)
  • Medtronic (US)
  • Oracle (US)
  • Change Healthcare (US)
  • Veradigm LLC  (US)
  • Merative (IBM) (US)
  • Google (US)
  • Cognizant (US)
  • Johnsons & Johnsons (US)
  • Amazon Web Services, Inc. (US)
  • SOPHiA GENETICS (US)
  • Riverian Technologies (US)
  • Terarecon (ConcertAI) (US)
  • 3M (US)
  • Tempus (US)
  • Viz.ai (US)
  • Recursion (US)
  • Qure.ai (India)
  • Atomwise Inc. (US)
  • Entilic (US)
  • Personify Health (US)
헬스케어 시장의 인공지능(AI) - 2030년까지의 세계 예측 ecosystem
artificial-intelligence-healthcare-market-Ecosystem

Research Coverage:

The report analyzes the Artificial Intelligence (AI) in healthcare market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Artificial Intelligence (AI) in healthcare market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (exponential growth in data volume and complexity due to surging adoption of digital technologies, significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases, rapid proliferation of AI in healthcare sector, growing need for improvised healthcare services), restraints (reluctance among medical practitioners to adopt AI-based technologies, shortage of skilled AI professionals handling AI-powered solutions, lack of standardized frameworks for AL and ML technologies), opportunities (increasing use of AI-powered solutions in elderly care, increasing focus on developing human-aware AI systems, rising use of technology in pharmaceuticals industry, strategic partnerships and collaborations among healthcare companies and AI technology providers), challenges (inaccurate predictions due to scarcity of high-quality healthcare data, concerns regarding data privacy, lack of interoperability between AI solutions offered by different vendors) are factors contributing the growth of the Artificial Intelligence (AI) in healthcare market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Artificial Intelligence (AI) in healthcare market.
  • Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Artificial Intelligence (AI) in healthcare market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Artificial Intelligence (AI) in healthcare market such as Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US).

Table of Contents

1               INTRODUCTION              57

1.1           STUDY OBJECTIVES       57

1.2           MARKET DEFINITION   57

1.3           STUDY SCOPE   58

1.3.1        MARKETS COVERED & REGIONAL SCOPE             58

1.3.2        INCLUSIONS & EXCLUSIONS       59

1.3.3        YEARS CONSIDERED      62

1.4           CURRENCY CONSIDERED            63

1.5           STAKEHOLDERS               63

1.6           SUMMARY OF CHANGES               64

2               RESEARCH METHODOLOGY       65

2.1           RESEARCH DATA              65

2.1.1        SECONDARY DATA          66

2.1.1.1    Key data from secondary sources       67

2.1.2        PRIMARY DATA 67

2.1.2.1    Key industry insights           69

2.2           MARKET SIZE ESTIMATION         70

2.3           MARKET BREAKDOWN & DATA TRIANGULATION                 75

2.4           MARKET SHARE ESTIMATION    77

2.5           STUDY ASSUMPTIONS  77

2.6           LIMITATIONS    77

2.6.1        METHODOLOGY-RELATED LIMITATIONS           77

2.6.2        SCOPE-RELATED LIMITATIONS                 77

2.7           RISK ASSESSMENT           78

3               EXECUTIVE SUMMARY  79

4               PREMIUM INSIGHTS       85

4.1           AI IN HEALTHCARE MARKET OVERVIEW               85

4.2           ASIA PACIFIC: AI IN HEALTHCARE, BY OFFERING AND COUNTRY (2024)               86

4.3           AI IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              87

4.4           AI IN HEALTHCARE MARKET: REGIONAL MIX (2022−2030)        87

4.5           AI IN HEALTHCARE: DEVELOPED VS. EMERGING MARKETS             88

5               MARKET OVERVIEW       89

5.1           INTRODUCTION              89

5.2           MARKET DYNAMICS       89

5.2.1        DRIVERS               91

5.2.1.1    Growing need for early detection and diagnosis              91

5.2.1.2    Exponential growth in data volume and complexity due to surging adoption of digital technologies         91

5.2.1.3    Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases         92

5.2.1.4    Rapid proliferation of AI in healthcare sector  92

5.2.1.5    Growing need for improvised healthcare services           93

5.2.2        RESTRAINTS      93

5.2.2.1    Reluctance among medical practitioners to adopt AI-based technologies           93

5.2.2.2    Shortage of skilled AI professionals handling AI-powered solutions 94

5.2.2.3    Lack of standardized frameworks for AL and ML technologies                 95

5.2.3        OPPORTUNITIES              95

5.2.3.1    Increasing use of AI-powered solutions in elderly care  95

5.2.3.2    Increasing focus on developing human-aware AI systems                 95

5.2.3.3    Strategic partnerships and collaborations among healthcare companies and AI technology providers           96

5.2.4        CHALLENGES    98

5.2.4.1    Inaccurate predictions due to scarcity of high-quality healthcare data         98

5.2.4.2    Concerns regarding data privacy        98

5.2.4.3    Lack of interoperability between AI solutions offered by different vendors  100

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       101

5.4           TECHNOLOGY ANALYSIS             101

5.4.1        KEY TECHNOLOGIES     101

5.4.1.1    Machine learning (ML) & deep learning          101

5.4.1.2    Natural language processing (NLP)  102

5.4.1.3    Computer vision (CV)         102

5.4.2        COMPLEMENTARY TECHNOLOGIES       102

5.4.2.1    Cloud computing  102

5.4.2.2    Digital twins          103

5.4.2.3    Robotic process automation (RPA)   103

5.4.3        ADJACENT TECHNOLOGIES       103

5.4.3.1    Blockchain             103

5.4.3.2    Augmented and virtual reality (AR/VR)           103

5.4.3.3    Internet of things (IoT)       104

5.5           INDUSTRY TRENDS         104

5.5.1        SHIFT TOWARD PERSONALIZED MEDICINE        104

5.5.2        AI IN DIAGNOSTICS AND IMAGING         104

5.6           PRICING ANALYSIS          105

5.6.1        INDICATIVE PRICING OF AI IN HEALTHCARE SOFTWARE, BY DEPLOYMENT MODEL (QUALITATIVE) 106

5.6.2        INDICATIVE PRICE TREND, BY REGION 106

5.7           VALUE CHAIN ANALYSIS               107

5.8           ECOSYSTEM ANALYSIS  109

5.9           PATENT ANALYSIS          111

5.10         KEY CONFERENCES & EVENTS, 2024–2025              115

5.11         CASE STUDY ANALYSIS 118

5.11.1      BIOBEAT LAUNCHED HOME-BASED REMOTE PATIENT MONITORING KIT DURING PEAK WAVE OF COVID-19    118

5.11.2      MICROSOFT COLLABORATED WITH CLEVELAND CLINIC TO APPLY PREDICTIVE AND ADVANCED ANALYTICS TO IDENTIFY POTENTIAL AT-RISK PATIENTS UNDER ICU CARE                 119

5.11.3      TGEN COLLABORATED WITH INTEL CORPORATION AND DELL TECHNOLOGIES TO ASSIST PHYSICIANS AND RESEARCHERS IN ACCELERATING DIAGNOSIS AND TREATMENT AT LOWER COSTS                119

5.11.4      GE HEALTHCARE IMPROVED PATIENT OUTCOMES BY REDUCING WORKFLOW PROCESSING TIME USING MEDICAL IMAGING DATA                 120

5.12         REGULATORY LANDSCAPE         120

5.12.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             121

5.12.2      REGULATORY FRAMEWORK       123

5.12.2.1  North America      123

5.12.2.2  Europe   125

5.12.2.3  Asia Pacific            125

5.12.2.4  Middle East & Africa            126

5.12.2.5  Latin America       127

5.13         PORTER’S FIVE FORCES ANALYSIS           127

5.13.1      THREAT OF NEW ENTRANTS      128

5.13.2      THREAT OF SUBSTITUTES          129

5.13.3      BARGAINING POWER OF SUPPLIERS       129

5.13.4      BARGAINING POWER OF BUYERS             129

5.13.5      INTENSITY OF COMPETITIVE RIVALRY 129

5.14         KEY STAKEHOLDERS & BUYING CRITERIA            130

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           130

5.14.2      BUYING CRITERIA           131

5.15         END-USER ANALYSIS      132

5.15.1      UNMET NEEDS 132

5.15.2      END-USER EXPECTATIONS         133

5.16         AI IN HEALTHCARE BUSINESS MODELS 134

5.16.1      SOFTWARE-AS-A-SERVICE (SAAS) MODEL            134

5.16.2      LICENSING MODEL         134

5.16.3      REVENUE SHARING/OUTCOME-BASED MODEL 134

5.16.4      FREEMIUM MODEL         134

5.16.5      AI-AS-A-SERVICE (AIAAS) MODEL             135

5.16.6      PARTNERSHIP/REVENUE-SHARING MODEL        135

5.16.7      HYBRID MODELS             135

5.16.8      PAY-PER-USE MODELS  135

5.17         INVESTMENT & FUNDING SCENARIO     135

5.18         IMPACT OF GENERATIVE AI ON AI IN HEALTHCARE MARKET               136

5.18.1      INTRODUCTION              136

5.18.2      MARKET POTENTIAL OF GEN AI IN HEALTHCARE                 136

5.18.2.1  Key use cases of Gen AI      137

5.18.3      CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION         138

5.18.3.1  Eka Care leveraging generative AI for improved health outcomes                 138

5.18.4      INTERCONNECTED AND ADJACENT ECOSYSTEMS                 139

5.18.4.1  AI in healthcare IT               139

5.18.4.2  AI in medical diagnostics    140

5.18.4.3  AI in oncology       140

5.18.4.4  AI in clinical trials 141

5.18.4.5  AI in drug discovery             141

5.18.5      USER READINESS & IMPACT ASSESSMENT            141

5.18.5.1  User readiness       141

5.18.5.1.1                Healthcare providers            141

5.18.5.1.2                Healthcare payers 142

5.18.5.1.3                Patients  142

5.18.5.2  Impact assessment                143

5.18.5.2.1                User A: Healthcare providers              143

5.18.5.2.1.1            Implementation    143

5.18.5.2.1.2            Impact    143

5.18.5.2.2                User B: Healthcare payers  143

5.18.5.2.2.1            Implementation    143

5.18.5.2.2.2            Impact    143

5.18.5.2.3                User C: Patients   144

5.18.5.2.3.1            Implementation    144

5.18.5.2.3.2            Impact    144

6               AI IN HEALTHCARE MARKET, BY OFFERING        145

6.1           INTRODUCTION              146

6.2           INTEGRATED SOLUTIONS           146

6.2.1        RISING WORKFORCE CHALLENGES AND COST PRESSURES TO DRIVE ADOPTION            146

6.3           NICHE/POINT SOLUTIONS          147

6.3.1        TARGETED AI SOLUTIONS TRANSFORMING PRECISION CARE AND EFFICIENCY IN HEALTHCARE TO BOOST MARKET                 147

6.4           AI TECHNOLOGIES         148

6.4.1        ABILITY OF CORE AI TECHNOLOGIES TO DRIVE PRECISION, EFFICIENCY, AND INNOVATION TO SUPPORT MARKET GROWTH          148

6.5           SERVICES             149

6.5.1        NEED FOR EMPOWERING NON-CLINICAL HEALTHCARE OPERATIONS TO ACCELERATE MARKET GROWTH          149

7               AI IN HEALTHCARE MARKET, BY FUNCTION       151

7.1           INTRODUCTION              152

7.2           DIAGNOSIS & EARLY DETECTION            152

7.2.1        PRE-SCREENING               154

7.2.1.1    Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market                 154

7.2.2        IVD         154

7.2.2.1    IVD market: By technology                 155

7.2.2.1.1 Immunoassays      156

7.2.2.1.1.1              Increasing focus on individualized therapies to drive market    156

7.2.2.1.2 Clinical chemistry 156

7.2.2.1.2.1              Increased demand for precision medicine and efficient healthcare systems to drive market    156

7.2.2.1.3 Molecular diagnostics          157

7.2.2.1.3.1              Improved disease detection, personalized treatments, and enhanced outcomes to fuel growth             157

7.2.2.2    IVD market: By application                158

7.2.2.2.1 Image analysis & interpretation          158

7.2.2.2.1.1              Advantages such as enhanced diagnostic accuracy, faster detection, and improved patient outcomes to support growth                 158

7.2.2.2.2 Biomarker discovery & analysis          159

7.2.2.2.2.1              Ability of AI-based biomarker discovery to enhance disease detection, prognosis, and personalized treatment to drive adoption                 159

7.2.2.2.3 Other IVD applications       160

7.2.3        DIAGNOSTIC IMAGING 160

7.2.3.1    Diagnostic imaging market: By application     161

7.2.3.1.1 Disease interpretation & report analysis           162

7.2.3.1.1.1              Ability of AI-driven disease interpretation to accelerate diagnosis, treatment, and outcomes to fuel growth         162

7.2.3.1.2 Image captioning & annotation          162

7.2.3.1.2.1              Enhanced diagnostic accuracy, efficiency, and consistency associated with image captioning & annotation to boost market    162

7.2.3.1.3 Image reconstruction           163

7.2.3.1.3.1              Improved diagnostic precision, efficiency, and image quality in healthcare to drive market 163

7.2.3.1.4 Other diagnostic imaging applications              164

7.2.3.2    Diagnostic imaging market: By modality          164

7.2.3.2.1 Magnetic resonance imaging (MRI) 165

7.2.3.2.1.1              Rising technological advancements to drive adoption of AI in MRI               165

7.2.3.2.2 Computed tomography (CT)              166

7.2.3.2.2.1              Rising availability of cardiac CT devices enabled with AI solutions to drive market     166

7.2.3.2.3 X-ray imaging        167

7.2.3.2.3.1              Innovative AI solutions for X-ray imaging by key players to drive market      167

7.2.3.2.4 Ultrasound             168

7.2.3.2.4.1              Increasing prevalence of ovarian cancer to drive market                 168

7.2.3.2.5 Nuclear imaging (PET & SPECT)    169

7.2.3.2.5.1              Critical role played by PET and SPECT in visualizing metabolic processes to contribute to growth    169

7.2.3.2.6 Other diagnostic imaging modalities 169

7.2.4        RISK ASSESSMENT & PATIENT STRATIFICATION                 170

7.2.4.1    AI-driven risk assessment and patient stratification to enhance healthcare efficiency, outcomes, and personalized care 170

7.2.5        DRUG ALLERGY ALERTING         171

7.2.5.1    Ability of AI-enhanced drug allergy alerting to improve accuracy, patient safety, and personalized care in healthcare to boost market                 171

7.2.6        OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS                 172

7.3           TREATMENT PLANNING & PERSONALIZATION 173

7.3.1        PERSONALIZED TREATMENT PLANNING             174

7.3.1.1    Precision medicine & genomic analysis            175

7.3.1.1.1 Advantages such as accurate disease predictions and improved outcomes to drive demand  175

7.3.1.2    Predictive models for treatment response        176

7.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth             176

7.3.1.3    Treatment recommendation systems                177

7.3.1.3.1 Optimized healthcare delivery associated with treatment recommendation systems to support growth   177

7.3.2        PHARMACOLOGICAL THERAPY                 178

7.3.2.1    Drug response prediction   179

7.3.2.1.1 Growing use of drug response prediction to minimize adverse reactions to aid growth        179

7.3.2.2    Dosing & administration     179

7.3.2.2.1 Improved efficacy and outcomes to fuel adoption           179

7.3.2.3    Other pharmacological therapy functions        180

7.3.3        SURGICAL THERAPY       181

7.3.3.1    Preoperative imaging & 3D modeling               182

7.3.3.1.1 Enhanced surgical planning and precision to propel market                 182

7.3.3.2    Intraoperative guidance & robotics   182

7.3.3.2.1 Faster recovery time to boost adoption             182

7.3.3.3    Postoperative analysis & recovery      183

7.3.3.3.1 Reduced complications to drive market            183

7.3.4        RADIATION THERAPY   184

7.3.4.1    Motion synchronization & auto contouring     185

7.3.4.1.1 Optimized radiation therapy with motion synchronization & auto contouring to boost market 185

7.3.4.2    Real-time adaptive treatment delivery               186

7.3.4.2.1 Reduced side effects to propel demand             186

7.3.4.3    Response assessment & quality assurance        186

7.3.4.3.1 Ability of AI to enhance response assessment and QA to spur growth    186

7.3.4.4    Other radiation therapy functions     187

7.3.5        BEHAVIORAL THERAPY & PSYCHOTHERAPY       188

7.3.5.1    Virtual counseling & chatbots             189

7.3.5.1.1 Ability to engage patients remotely to drive market demand                 189

7.3.5.2    Progress monitoring & feedback        189

7.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market    189

7.3.5.3    Follow-up & long-term support         190

7.3.5.3.1 Widespread adoption of telemedicine platforms to drive market demand  190

7.3.6        IMMUNOTHERAPY          191

7.3.6.1    Real-time patient data monitoring     192

7.3.6.1.1 Need for real-time data analysis to make informed decisions to boost market growth             192

7.3.6.2    Response & side-effect prediction     193

7.3.6.2.1 Ability to reduce trial and error approach in medical treatments to drive market growth        193

7.3.6.3    Relapse prediction & long-term management 193

7.3.6.3.1 Need for proactive approach for long-term care to fuel market growth    193

7.3.7        OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS       194

7.4           PATIENT ENGAGEMENT & REMOTE MONITORING                 195

7.4.1        SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE                 196

7.4.1.1    Rising prevalence of chronic diseases to drive market growth                 196

7.4.2        TELEHEALTH & REMOTE PATIENT MONITORING                 197

7.4.2.1    Ability to monitor and evaluate patients remotely to boost market demand  197

7.4.3        HEALTHCARE ASSISTANCE ROBOTS       197

7.4.3.1    Advancements in robotics and artificial intelligence (AI) to boost market demand     197

7.4.4        MEDICATION REMINDERS           198

7.4.4.1    Increasing adoption of smartphone applications and IoT devices to surge market demand      198

7.4.5        PATIENT EDUCATION & EMPOWERMENT            199

7.4.5.1    Need to improve treatment adherence and enhance self-management to drive market growth 199

7.4.6        OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS         200

7.5           POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE     201

7.5.1        RECURRENCE MONITORING      202

7.5.1.1    Need to predict recurrence of cancer to drive market    202

7.5.2        LONG-TERM OUTCOME PREDICTION   202

7.5.2.1    Ability to predict long-term health outcomes and enhance patient care to drive market              202

7.5.3        MENTAL HEALTH & SUPPORT SYSTEMS                203

7.5.3.1    Need to help patients cope with mental strain to drive market                 203

7.6           PHARMACY MANAGEMENT        204

7.6.1        EPRESCRIBING 205

7.6.1.1    Need to improve safety and efficiency in prescribing to drive market    205

7.6.2        MEDICATION MANAGEMENT    205

7.6.2.1    Ability to predict adverse drug reactions by patient data analysis to drive market      205

7.6.3        PHARMACY AUDIT & ANALYSIS 206

7.6.3.1    Need for effective and efficient operation of pharmacies to drive market    206

7.6.4        OTHER PHARMACY MANAGEMENT FUNCTIONS                 207

7.7           DATA MANAGEMENT & ANALYTICS        208

7.7.1        ABILITY OF DATA MANAGEMENT & ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS MAKE INFORMED DECISIONS TO BOOST MARKET                208

7.8           ADMINISTRATIVE            208

7.8.1        PATIENT REGISTRATION & SCHEDULING            210

7.8.1.1    Need to optimize patient registration process to drive market                 210

7.8.2        PATIENT ELIGIBILITY & AUTHORIZATION           211

7.8.2.1    Need to reduce administrative burden to drive market  211

7.8.3        BILLING & CLAIMS MANAGEMENT          212

7.8.3.1    Need to make billing process more accurate, efficient, and transparent to drive market                 212

7.8.4        WORKFORCE MANAGEMENT     213

7.8.4.1    Need for effective staff management to drive market     213

7.8.5        SUPPLY CHAIN & INVENTORY MANAGEMENT   214

7.8.5.1    Ability to make better procurement decisions to drive market                 214

7.8.6        COMPLIANCE & DOCUMENTATION        215

7.8.6.1    Need to reduce manual paperwork and errors to drive market                 215

7.8.7        HEALTHCARE WORKFLOW MANAGEMENT         216

7.8.7.1    Need to optimize and automate processes within healthcare facilities to drive market      216

7.8.8        ASSET MANAGEMENT   217

7.8.8.1    Ability to optimize use and allocation of resources to drive market                 217

7.8.9        CUSTOMER RELATIONSHIP MANAGEMENT        218

7.8.9.1    Enhancing patient engagement and retention through AI-driven CRM systems to boost market            218

7.8.10      FRAUD DETECTION & RISK MANAGEMENT         219

7.8.10.1  Need to enhance security in healthcare systems to drive market demand  219

7.8.11      CYBERSECURITY              220

7.8.11.1  Enhancing healthcare cybersecurity with AI-driven threat detection and risk management to fuel growth                220

7.8.12      OTHER ADMINISTRATIVE FUNCTIONS 221

8               AI IN HEALTHCARE MARKET, BY APPLICATION 222

8.1           INTRODUCTION              223

8.2           CLINICAL APPLICATIONS            223

8.2.1        ABILITY OF AI TO IMPROVE DIAGNOSTICS, TREATMENT, AND PATIENT CARE TO DRIVE MARKET GROWTH                 223

8.3           NON-CLINICAL APPLICATIONS 225

8.3.1        ABILITY OF AI TO REDUCE ADMINISTRATIVE BURDENS AND ENSURE BETTER RESOURCE ALLOCATION TO FUEL GROWTH             225

9               AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL                 227

9.1           INTRODUCTION              228

9.2           ON-PREMISE MODELS   228

9.2.1        ENHANCED DATA SECURITY AND COMPLIANCE TO PROPEL ADOPTION OF ON-PREMISE AI MODELS             228

9.3           CLOUD-BASED MODELS               229

9.3.1        SCALABILITY AND AUTOMATION OF CLOUD-BASED AI PLATFORMS TO RESHAPE HEALTHCARE DELIVERY GLOBALLY                 229

9.4           HYBRID MODELS             231

9.4.1        FLEXIBILITY FOR DIVERSE APPLICATIONS TO BOOST DEMAND FOR HYBRID MODELS                231

10            ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TOOL              232

10.1         INTRODUCTION              233

10.2         MACHINE LEARNING     233

10.2.1      DEEP LEARNING               235

10.2.1.1  Convolutional neural networks (CNN)             237

10.2.1.1.1                Growing demand for advance medical imaging and diagnostics to drive market growth    237

10.2.1.2  Recurrent neural networks (RNN)    238

10.2.1.2.1                Ability of RNN to enhance predictive analytics in healthcare to boost market  238

10.2.1.3  Generative adversarial networks (GAN)          238

10.2.1.3.1                Ability to transform data scarcity and privacy in AI-driven healthcare to drive demand for GAN    238

10.2.1.4  Graph neural networks (GNN)          239

10.2.1.4.1                Ability of GNN to revolutionize relational insights in healthcare analytics to fuel growth    239

10.2.1.5  Other deep learning tools   240

10.2.2      SUPERVISED LEARNING                240

10.2.2.1  Need to drive precision and efficiency in healthcare to support adoption of supervised learning tools                240

10.2.3      REINFORCEMENT LEARNING     241

10.2.3.1  Wide usage of reinforcement learning models for real-time and adaptive healthcare solutions to support market growth                241

10.2.4      UNSUPERVISED LEARNING         242

10.2.4.1  Ability of unsupervised learning to drive innovation in healthcare analytics to propel market   242

10.2.5      OTHER MACHINE LEARNING TOOLS      243

10.3         NATURAL LANGUAGE PROCESSING (NLP)           244

10.3.1      SENTIMENT ANALYSIS  245

10.3.1.1  Enhanced patient experience and operational insights to spur demand for sentiment analysis           245

10.3.2      PATTERN & IMAGE RECOGNITION          246

10.3.2.1  Increased precision in clinical decision-making associated with pattern & image recognition to aid market       246

10.3.3      AUTO CODING 246

10.3.3.1  Advantages such as improved medical billing and administrative efficiency to boost market   246

10.3.4      CLASSIFICATION & CATEGORIZATION  247

10.3.4.1  Ability of classification & categorization to organize healthcare data for better outcomes to propel market       247

10.3.5      TEXT ANALYTICS             248

10.3.5.1  Ability to transform unstructured data into actionable healthcare insights to fuel growth         248

10.3.6      SPEECH RECOGNITION 248

10.3.6.1  Improved speech recognition advancing real-time documentation and accessibility to drive demand      248

10.4         CONTEXT-AWARE COMPUTING                249

10.4.1      DEVICE CONTEXT           250

10.4.1.1  Real-time monitoring and decision-making to contribute to market growth       250

10.4.2      USER CONTEXT                251

10.4.2.1  Personalized healthcare and adaptive workflows to drive demand                 251

10.4.3      PHYSICAL CONTEXT      252

10.4.3.1  Location-based services associated with physical context to generate demand  252

10.5         GENERATIVE AI                253

10.5.1      ABILITY OF GENERATIVE AI MODELS TO MIMIC DISEASE PROGRESSION TO DRIVE MARKET        253

10.6         COMPUTER VISION        254

10.6.1      ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS TO FUEL ADOPTION  254

10.7         IMAGE ANALYSIS              255

10.7.1      STREAMLINING DOCUMENT MANAGEMENT TO PROPEL MARKET             255

11            AI IN HEALTHCARE MARKET, BY END USER        257

11.1         INTRODUCTION              258

11.2         HEALTHCARE PROVIDERS           258

11.2.1      HOSPITALS & CLINICS   261

11.2.1.1  Growing need to improve profitability of healthcare to drive use of AI-based healthcare solutions in hospitals   261

11.2.2      AMBULATORY CARE CENTERS  262

11.2.2.1  Supportive government norms and incentives for HCIT solutions and services to drive market growth  262

11.2.3      HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES         263

11.2.3.1  Growing need for long-term home care to drive market growth                 263

11.2.4      DIAGNOSTIC & IMAGING CENTERS         264

11.2.4.1  Growing burden of various chronic diseases to propel market growth    264

11.2.5      PHARMACIES     266

11.2.5.1  Advantages of workflow improvements and error reduction to drive AI-based healthcare solution adoption in pharmacies          266

11.2.6      OTHER HEALTHCARE PROVIDERS           267

11.3         HEALTHCARE PAYERS   267

11.3.1      PUBLIC PAYERS                268

11.3.1.1  Focus on developing outcome-based payment models to drive demand for payer solutions 268

11.3.2      PRIVATE PAYERS              269

11.3.2.1  Possible increases in operational efficiency to boost demand among private payers           269

11.4         PATIENTS            270

11.4.1      RISE IN USE OF AI IN MENTAL HEALTH SUPPORT APPLICATIONS THROUGH CHATBOTS AND VIRTUAL THERAPISTS TO BOOST MARKET             270

11.5         OTHER END USERS         271

12            AI IN HEALTHCARE MARKET, BY REGION             273

12.1         INTRODUCTION              274

12.2         NORTH AMERICA             275

12.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 277

12.2.2      US           292

12.2.2.1  Rising adoption of advanced medical imaging and regulatory support to drive market       292

12.2.3      CANADA               307

12.2.3.1  Growing burden of chronic diseases and research grants for AI to drive market growth             307

12.3         EUROPE               322

12.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      324

12.3.2      GERMANY           339

12.3.2.1  Advanced healthcare system and government efforts to drive growth    339

12.3.3      UK          354

12.3.3.1  Government support and new AI platform emergence to boost market    354

12.3.4      FRANCE                369

12.3.4.1  Thriving AI ecosystem and strategic partnerships to boost healthcare innovation           369

12.3.5      ITALY    384

12.3.5.1  Regulatory reforms, strategic investments, and aging population to propel growth   384

12.3.6      SPAIN    399

12.3.6.1  Established network of research centers to propel market                 399

12.3.7      REST OF EUROPE             414

12.4         ASIA PACIFIC     429

12.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 431

12.4.2      CHINA  446

12.4.2.1  Expanding AI applications in medical imaging and diagnostics to drive market growth             446

12.4.3      JAPAN   461

12.4.3.1  Strong healthcare infrastructure to drive uptake of advanced AI                 461

12.4.4      INDIA    476

12.4.4.1  Favorable government initiatives for R&D investments to drive market    476

12.4.5      REST OF ASIA PACIFIC   491

12.5         LATIN AMERICA                506

12.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 507

12.5.2      BRAZIL 523

12.5.2.1  AI initiatives to drive healthcare innovation and accessibility                 523

12.5.3      MEXICO                537

12.5.3.1  AI to revolutionize healthcare delivery and outcomes    537

12.5.4      REST OF LATIN AMERICA             552

12.6         MIDDLE EAST & AFRICA                567

12.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 568

12.6.2      GCC COUNTRIES              583

12.6.2.1  AI-driven innovations and rising healthcare investments to propel market growth           583

12.6.3      REST OF MIDDLE EAST & AFRICA             598

13            COMPETITIVE LANDSCAPE         614

13.1         INTRODUCTION              614

13.2         KEY PLAYER STRATEGY/RIGHT TO WIN                614

13.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET                 614

13.3         REVENUE ANALYSIS, 2019–2023  617

13.4         MARKET SHARE ANALYSIS, 2023                 618

13.4.1      RANKING OF KEY MARKET PLAYERS       621

13.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 621

13.5.1      STARS   621

13.5.2      EMERGING LEADERS     621

13.5.3      PERVASIVE PLAYERS      621

13.5.4      PARTICIPANTS 622

13.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         623

13.5.5.1  Company footprint               623

13.5.5.2  Region footprint   624

13.5.5.3  Application footprint            625

13.5.5.4  Tool footprint        626

13.5.5.5  Function footprint                627

13.5.5.6  Offering footprint 628

13.5.5.7  Deployment footprint          629

13.5.5.8  End-user footprint                630

13.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        631

13.6.1      PROGRESSIVE COMPANIES         631

13.6.2      RESPONSIVE COMPANIES            631

13.6.3      DYNAMIC COMPANIES  631

13.6.4      STARTING BLOCKS         631

13.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 633

13.7         COMPANY VALUATION & FINANCIAL METRICS 634

13.7.1      FINANCIAL METRICS      634

13.7.2      COMPANY VALUATION 634

13.8         BRAND/PRODUCT COMPARISON             635

13.9         COMPETITIVE SCENARIO             636

13.9.1      PRODUCT LAUNCHES   636

13.9.2      DEALS  637

13.9.3      OTHER DEVELOPMENTS              638

14            COMPANY PROFILES      640

14.1         KEY PLAYERS     640

14.1.1      KONINKLIJKE PHILIPS N.V.          640

14.1.1.1  Business overview 640

14.1.1.2  Products & services offered                 641

14.1.1.3  Recent developments           644

14.1.1.3.1                Product launches  644

14.1.1.3.2                Deals      645

14.1.1.3.3                Expansions             646

14.1.1.3.4                Other developments             646

14.1.1.4  MnM view              647

14.1.1.4.1                Right to win           647

14.1.1.4.2                Strategic choices   647

14.1.1.4.3                Weaknesses & competitive threats     647

14.1.2      MICROSOFT CORPORATION      648

14.1.2.1  Business overview 648

14.1.2.2  Products & services offered                 650

14.1.2.3  Recent developments           651

14.1.2.3.1                Product launches  651

14.1.2.3.2                Deals      652

14.1.2.4  MnM view              654

14.1.2.4.1                Right to win           654

14.1.2.4.2                Strategic choices   654

14.1.2.4.3                Weaknesses & competitive threats     655

14.1.3      NVIDIA CORPORATION 656

14.1.3.1  Business overview 656

14.1.3.2  Products & services offered                 657

14.1.3.3  Recent developments           658

14.1.3.3.1                Product launches  658

14.1.3.3.2                Deals      659

14.1.3.4  MnM view              660

14.1.3.4.1                Right to win           660

14.1.3.4.2                Strategic choices   660

14.1.3.4.3                Weaknesses & competitive threats     660

14.1.4      SIEMENS HEALTHINEERS AG      661

14.1.4.1  Business overview 661

14.1.4.2  Products & services offered                 663

14.1.4.3  Recent developments           664

14.1.4.3.1                Product launches & enhancements    664

14.1.4.3.2                Deals      664

14.1.4.3.3                Other developments             665

14.1.4.4  MnM view              666

14.1.4.4.1                Right to win           666

14.1.4.4.2                Strategic choices   666

14.1.4.4.3                Weaknesses & competitive threats     666

14.1.5      GE HEALTHCARE             667

14.1.5.1  Business overview 667

14.1.5.2  Products & services offered                 669

14.1.5.3  Recent developments           670

14.1.5.3.1                Deals      670

14.1.6      EPIC SYSTEMS CORPORATION  672

14.1.6.1  Business overview 672

14.1.6.2  Products & services offered                 672

14.1.6.3  Recent developments           673

14.1.6.3.1                Deals      673

14.1.7      ORACLE                674

14.1.7.1  Business overview 674

14.1.7.2  Products & services offered                 676

14.1.7.3  Recent developments           677

14.1.7.3.1                Product launches  677

14.1.7.3.2                Deals      677

14.1.8      VERADIGM LLC 679

14.1.8.1  Business overview 679

14.1.8.2  Products & services offered                 680

14.1.8.3  Recent developments           681

14.1.8.3.1                Deals      681

14.1.9      AMAZON WEB SERVICES, INC.    682

14.1.9.1  Business overview 682

14.1.9.2  Products & services offered                 683

14.1.9.3  Recent developments           684

14.1.9.3.1                Product launches  684

14.1.9.3.2                Deals      685

14.1.10   MERATIVE (IBM)              686

14.1.10.1                 Business overview 686

14.1.10.2                 Products & services offered                 687

14.1.10.3                 Recent developments           688

14.1.10.3.1             Product launches  688

14.1.10.3.2             Deals      689

14.1.11   MEDTRONIC      690

14.1.11.1                 Business overview 690

14.1.11.2                 Products & services offered                 691

14.1.11.3                 Recent developments           692

14.1.11.3.1             Deals      692

14.1.12   GOOGLE              693

14.1.12.1                 Business overview 693

14.1.12.2                 Products & services offered                 694

14.1.12.3                 Recent developments           695

14.1.12.3.1             Product launches  695

14.1.12.3.2             Deals      696

14.1.12.3.3             Other developments             697

14.1.13   SOPHIA GENETICS          698

14.1.13.1                 Business overview 698

14.1.13.2                 Products & services offered                 699

14.1.13.3                 Recent developments           699

14.1.13.3.1             Deals      699

14.1.14   JOHNSON & JOHNSON SERVICES, INC.   700

14.1.14.1                 Business overview 700

14.1.14.2                 Products & services offered                 701

14.1.14.3                 Recent developments           702

14.1.14.3.1             Deals      702

14.1.15   TEMPUS               703

14.1.15.1                 Business overview 703

14.1.15.2                 Products & services offered                 704

14.1.15.3                 Recent developments           705

14.1.15.3.1             Product launches & approvals            705

14.1.15.3.2             Deals      705

14.1.16   TERARECON (CONCERTAI)         706

14.1.16.1                 Business overview 706

14.1.16.2                 Products & services offered                 706

14.1.16.3                 Recent developments           707

14.1.16.3.1             Product launches & upgrades             707

14.1.16.3.2             Deals      708

14.1.17   3M           709

14.1.17.1                 Business overview 709

14.1.17.2                 Products & services offered                 710

14.1.17.3                 Recent developments           710

14.1.17.3.1             Deals      710

14.1.18   COGNIZANT      711

14.1.18.1                 Business overview 711

14.1.18.2                 Products & services offered                 712

14.1.18.3                 Recent developments           713

14.1.18.3.1             Product launches & upgrades             713

14.1.18.3.2             Deals      714

14.1.19   VIZ.AI, INC.         715

14.1.19.1                 Business overview 715

14.1.19.2                 Products & services offered                 715

14.1.19.3                 Recent developments           716

14.1.19.3.1             Product launches  716

14.1.19.3.2             Deals      716

14.1.19.3.3             Other developments             718

14.1.20   RIVERAIN TECHNOLOGIES          719

14.1.20.1                 Business overview 719

14.1.20.2                 Products & services offered                 719

14.1.20.3                 Recent developments           720

14.1.20.3.1             Deals      720

14.2         OTHER PLAYERS              721

14.2.1      QVENTUS            721

14.2.2      QURE.AI               722

14.2.3      ATOMWISE INC.                723

14.2.4      ENLITIC                724

14.2.5      SEGMED               725

15            APPENDIX           726

15.1         DISCUSSION GUIDE        726

15.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                734

15.3         CUSTOMIZATION OPTIONS        736

15.4         RELATED REPORTS         736

15.5         AUTHOR DETAILS           737

LIST OF TABLES

TABLE 1                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD                63

TABLE 2                AI IN HEALTHCARE MARKET: RISK ASSESSMENT                 78

TABLE 3                AI IN HEALTHCARE MARKET: IMPACT ANALYSIS                 90

TABLE 4                AI IN HEALTHCARE MARKET: AVERAGE SELLING PRICE, BY REGION (2021–2023)                 106

TABLE 5                COMPANIES AND THEIR ROLES IN AI IN HEALTHCARE ECOSYSTEM         110

TABLE 6                AI IN HEALTHCARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS 111

TABLE 7                AI IN HEALTHCARE MARKET: LIST OF CONFERENCES & EVENTS, 2024–2025       115

TABLE 8                NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             121

TABLE 9                EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 122

TABLE 10              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 122

TABLE 11              ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS       127

TABLE 12              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS  130

TABLE 13              KEY BUYING CRITERIA FOR TOP THREE END USERS   131

TABLE 14              UNMET NEEDS IN AI IN HEALTHCARE MARKET                 132

TABLE 15              END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET 133

TABLE 16              AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)            146

TABLE 17              AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION, 2022–2030 (USD MILLION)        147

TABLE 18              AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION, 2022–2030 (USD MILLION)        148

TABLE 19              AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION, 2022–2030 (USD MILLION)                 149

TABLE 20              AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION, 2022–2030 (USD MILLION)          150

TABLE 21              AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            152

TABLE 22              AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            153

TABLE 23              AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)            153

TABLE 24              AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION, 2022–2030 (USD MILLION)         154

TABLE 25              AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2022–2030 (USD MILLION)          155

TABLE 26              AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            155

TABLE 27              AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION, 2022–2030 (USD MILLION)                 156

TABLE 28              AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2022–2030 (USD MILLION)        157

TABLE 29              AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022–2030 (USD MILLION)    157

TABLE 30              AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)              158

TABLE 31              AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2022–2030 (USD MILLION)            159

TABLE 32              AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2022–2030 (USD MILLION)                 159

TABLE 33              AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)  160

TABLE 34              AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION, 2022–2030 (USD MILLION)              161

TABLE 35              AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION) 161

TABLE 36              AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2022–2030 (USD MILLION) 162

TABLE 37              AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2022–2030 (USD MILLION)            163

TABLE 38              AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION, 2022–2030 (USD MILLION)                 163

TABLE 39              AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 164

TABLE 40              AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)       165

TABLE 41              AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2022–2030 (USD MILLION)            166

TABLE 42              AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2022–2030 (USD MILLION)                 167

TABLE 43              AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION, 2022–2030 (USD MILLION)              167

TABLE 44              AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION, 2022–2030 (USD MILLION)   168

TABLE 45              AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING (PET & SPECT), BY REGION, 2022–2030 (USD MILLION)                 169

TABLE 46              AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES, BY REGION, 2022–2030 (USD MILLION) 170

TABLE 47              AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2022–2030 (USD MILLION)       171

TABLE 48              AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION, 2022–2030 (USD MILLION)                 172

TABLE 49              AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)            172

TABLE 50              AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)       173

TABLE 51              AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)            174

TABLE 52              AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 174

TABLE 53              AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY REGION, 2022–2030 (USD MILLION) 175

TABLE 54              AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS, BY REGION, 2022–2030 (USD MILLION)            176

TABLE 55              AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2022–2030 (USD MILLION) 177

TABLE 56              AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS, BY REGION, 2022–2030 (USD MILLION)            177

TABLE 57              AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            178

TABLE 58              AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2022–2030 (USD MILLION)            178

TABLE 59              AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2022–2030 (USD MILLION)                 179

TABLE 60              AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION, 2022–2030 (USD MILLION)                 180

TABLE 61              AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)       180

TABLE 62              AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)   181

TABLE 63              AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION, 2022–2030 (USD MILLION)              181

TABLE 64              AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING, BY REGION, 2022–2030 (USD MILLION)       182

TABLE 65              AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS, BY REGION, 2022–2030 (USD MILLION)       183

TABLE 66              AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY, BY REGION, 2022–2030 (USD MILLION) 184

TABLE 67              AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)   184

TABLE 68              AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION, 2022–2030 (USD MILLION)              185

TABLE 69              AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2022–2030 (USD MILLION)       185

TABLE 70              AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY, BY REGION, 2022–2030 (USD MILLION)            186

TABLE 71              AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2022–2030 (USD MILLION) 187

TABLE 72              AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)            187

TABLE 73              AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            188

TABLE 74              AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY REGION, 2022–2030 (USD MILLION)            188

TABLE 75              AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2022–2030 (USD MILLION)            189

TABLE 76              AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK, BY REGION, 2022–2030 (USD MILLION)            190

TABLE 77              AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2022–2030 (USD MILLION)                 191

TABLE 78              AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 191

TABLE 79              AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION, 2022–2030 (USD MILLION)                 192

TABLE 80              AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING, BY REGION, 2022–2030 (USD MILLION)            192

TABLE 81              AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION, BY REGION, 2022–2030 (USD MILLION)            193

TABLE 82              AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)       194

TABLE 83              AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)          194

TABLE 84              AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            195

TABLE 85              AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)          196

TABLE 86              AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2022–2030 (USD MILLION) 196

TABLE 87              AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION)            197

TABLE 88              AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2022–2030 (USD MILLION)                 198

TABLE 89              AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION, 2022–2030 (USD MILLION)        199

TABLE 90              AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT, BY REGION, 2022–2030 (USD MILLION)            200

TABLE 91              AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)   200

TABLE 92              AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)              201

TABLE 93              AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)        201

TABLE 94              AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION, 2022–2030 (USD MILLION)    202

TABLE 95              AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2022–2030 (USD MILLION)                 203

TABLE 96              AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS, BY REGION, 2022–2030 (USD MILLION)            203

TABLE 97              AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)                 204

TABLE 98              AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)            204

TABLE 99              AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION, 2022–2030 (USD MILLION)  205

TABLE 100            AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)  206

TABLE 101            AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2022–2030 (USD MILLION)                 207

TABLE 102            AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 207

TABLE 103            AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)       208

TABLE 104            AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            209

TABLE 105            AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)            210

TABLE 106            AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING, BY REGION, 2022–2030 (USD MILLION)            211

TABLE 107            AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION, BY REGION, 2022–2030 (USD MILLION)            212

TABLE 108            AI IN HEALTHCARE MARKET FOR BILLING & CLAIMS MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)                 213

TABLE 109            AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)  214

TABLE 110            AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT, BY REGION, 2022–2030 (USD MILLION) 215

TABLE 111            AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2022–2030 (USD MILLION)                 216

TABLE 112            AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)            217

TABLE 113            AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)  218

TABLE 114            AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)            219

TABLE 115            AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT, BY REGION, 2022–2030 (USD MILLION)            220

TABLE 116            AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION, 2022–2030 (USD MILLION)                 221

TABLE 117            AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2022–2030 (USD MILLION)            221

TABLE 118            AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            223

TABLE 119            AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)  224

TABLE 120            AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2022–2030 (USD MILLION)            226

TABLE 121            AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)           228

TABLE 122            AI IN HEALTHCARE MARKET FOR ON-PREMISE MODELS, BY REGION, 2022–2030 (USD MILLION)               229

TABLE 123            AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODELS, BY REGION, 2022–2030 (USD MILLION)                 230

TABLE 124            AI IN HEALTHCARE MARKET FOR HYBRID MODELS, BY REGION, 2022–2030 (USD MILLION)               231

TABLE 125            AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)       233

TABLE 126            AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 234

TABLE 127            AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION, 2022–2030 (USD MILLION)           235

TABLE 128            AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 236

TABLE 129            AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION, 2022–2030 (USD MILLION)           237

TABLE 130            AI IN HEALTHCARE MARKET FOR CONVULATIONAL NEURAL NETWORKS (CNN), BY REGION, 2022–2030 (USD MILLION)            237

TABLE 131            AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS (RNN), BY REGION, 2022–2030 (USD MILLION)            238

TABLE 132            AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS (GAN), BY REGION, 2022–2030 (USD MILLION)            239

TABLE 133            AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS (GNN), BY REGION, 2022–2030 (USD MILLION)            239

TABLE 134            AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2022–2030 (USD MILLION)                 240

TABLE 135            AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION, 2022–2030 (USD MILLION)           241

TABLE 136            AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2022–2030 (USD MILLION)            242

TABLE 137            AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2022–2030 (USD MILLION)            243

TABLE 138            AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2022–2030 (USD MILLION)            243

TABLE 139            AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY TYPE, 2022–2030 (USD MILLION)            244

TABLE 140            AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2022–2030 (USD MILLION)            245

TABLE 141            AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION, 2022–2030 (USD MILLION)             245

TABLE 142            AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2022–2030 (USD MILLION)                 246

TABLE 143            AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION, 2022–2030 (USD MILLION)                247

TABLE 144            AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2022–2030 (USD MILLION) 247

TABLE 145            AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION, 2022–2030 (USD MILLION)         248

TABLE 146            AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION, 2022–2030 (USD MILLION)  249

TABLE 147            AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)                 250

TABLE 148            AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2022–2030 (USD MILLION)                 250

TABLE 149            AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION, 2022–2030 (USD MILLION)             251

TABLE 150            AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION, 2022–2030 (USD MILLION)             252

TABLE 151            AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION, 2022–2030 (USD MILLION)             253

TABLE 152            AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION, 2022–2030 (USD MILLION)             254

TABLE 153            AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION, 2022–2030 (USD MILLION)  255

TABLE 154            AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION, 2022–2030 (USD MILLION)             256

TABLE 155            AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)            258

TABLE 156            AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)               260

TABLE 157            AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)         260

TABLE 158            AI IN HEALTHCARE MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)   262

TABLE 159            AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2022–2030 (USD MILLION)            263

TABLE 160            AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)          264

TABLE 161            AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2022–2030 (USD MILLION)                 265

TABLE 162            AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION, 2022–2030 (USD MILLION)   266

TABLE 163            AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2022–2030 (USD MILLION)            267

TABLE 164            AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)       268

TABLE 165            AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2022–2030 (USD MILLION) 268

TABLE 166            AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION, 2022–2030 (USD MILLION) 269

TABLE 167            AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION, 2022–2030 (USD MILLION) 270

TABLE 168            AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION, 2022–2030 (USD MILLION)          271

TABLE 169            AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)    272

TABLE 170            AI IN HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION)       274

TABLE 171            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)               277

TABLE 172            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)               278

TABLE 173            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)             278

TABLE 174            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            279

TABLE 175            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)  279

TABLE 176            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)   280

TABLE 177            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            280

TABLE 178            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            281

TABLE 179            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)            281

TABLE 180            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)       282

TABLE 181            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            282

TABLE 182            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 283

TABLE 183            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 283

TABLE 184            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            284

TABLE 185            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 284

TABLE 186            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)                285

TABLE 187            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)         285

TABLE 188            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)            286

TABLE 189            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            287

TABLE 190            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)       288

TABLE 191            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     288

TABLE 192            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)       289

TABLE 193            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 289

TABLE 194            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 290

TABLE 195            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 290

TABLE 196            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            291

TABLE 197            NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)               291

TABLE 198            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)            292

TABLE 199            NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 292

TABLE 200            US: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)            293

TABLE 201            US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            294

TABLE 202            US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            294

TABLE 203            US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            295

TABLE 204            US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)              295

TABLE 205            US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            296

TABLE 206            US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            296

TABLE 207            US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       297

TABLE 208            US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 297

TABLE 209            US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            298

TABLE 210            US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)   298

TABLE 211            US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 299

TABLE 212            US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 299

TABLE 213            US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 300

TABLE 214            US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 300

TABLE 215            US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)            301

TABLE 216            US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 301

TABLE 217            US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            302

TABLE 218            US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              302

TABLE 219            US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            303

TABLE 220            US: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            303

TABLE 221            US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 304

TABLE 222            US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 304

TABLE 223            US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)                 305

TABLE 224            US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            305

TABLE 225            US: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)            306

TABLE 226            US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 306

TABLE 227            US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 307

TABLE 228            CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     308

TABLE 229            CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   308

TABLE 230            CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            309

TABLE 231            CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)     309

TABLE 232            CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)       310

TABLE 233            CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            310

TABLE 234            CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            311

TABLE 235            CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       311

TABLE 236            CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 312

TABLE 237            CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            312

TABLE 238            CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 313

TABLE 239            CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 313

TABLE 240            CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 314

TABLE 241            CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 314

TABLE 242            CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            315

TABLE 243            CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                315

TABLE 244            CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 316

TABLE 245            CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            317

TABLE 246            CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              317

TABLE 247            CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            318

TABLE 248            CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)              318

TABLE 249            CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 319

TABLE 250            CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)     319

TABLE 251            CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            320

TABLE 252            CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            320

TABLE 253            CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                321

TABLE 254            CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 321

TABLE 255            CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 322

TABLE 256            EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)     324

TABLE 257            EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     325

TABLE 258            EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   325

TABLE 259            EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            326

TABLE 260            EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)     326

TABLE 261            EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)       327

TABLE 262            EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            327

TABLE 263            EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            328

TABLE 264            EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       328

TABLE 265            EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 329

TABLE 266            EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            329

TABLE 267            EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 330

TABLE 268            EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 330

TABLE 269            EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 331

TABLE 270            EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 331

TABLE 271            EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            332

TABLE 272            EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                332

TABLE 273            EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 333

TABLE 274            EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            334

TABLE 275            EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              334

TABLE 276            EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            335

TABLE 277          EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            335

TABLE 278            EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 336

TABLE 279            EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)     336

TABLE 280            EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            337

TABLE 281            EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            337

TABLE 282            EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                338

TABLE 283            EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 338

TABLE 284            EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 339

TABLE 285            GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     340

TABLE 286            GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   340

TABLE 287            GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            341

TABLE 288            GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            341

TABLE 289            GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)             342

TABLE 290            GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            342

TABLE 291            GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            343

TABLE 292            GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       343

TABLE 293            GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 344

TABLE 294            GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            344

TABLE 295            GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 345

TABLE 296            GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 345

TABLE 297            GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 346

TABLE 298            GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 346

TABLE 299            GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            347

TABLE 300            GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                347

TABLE 301            GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 348

TABLE 302            GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            349

TABLE 303            GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              349

TABLE 304            GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            350

TABLE 305            GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)              350

TABLE 306            GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 351

TABLE 307            GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)     351

TABLE 308            GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            352

TABLE 309            GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            352

TABLE 310            GERMANY: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)     353

TABLE 311            GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 353

TABLE 312            GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 354

TABLE 313            UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)            355

TABLE 314          UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            355

TABLE 315            UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            356

TABLE 316            UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            356

TABLE 317            UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)              357

TABLE 318            UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            357

TABLE 319            UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            358

TABLE 320            UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       358

TABLE 321            UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 359

TABLE 322            UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            359

TABLE 323            UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)   360

TABLE 324            UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 360

TABLE 325            UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 361

TABLE 326            UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 361

TABLE 327            UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION) 362

TABLE 328            UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)            362

TABLE 329            UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 363

TABLE 330            UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            364

TABLE 331            UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              364

TABLE 332            UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            365

TABLE 333            UK: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            365

TABLE 334            UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION) 366

TABLE 335            UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 366

TABLE 336            UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)                 367

TABLE 337            UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            367

TABLE 338            UK: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)            368

TABLE 339            UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 368

TABLE 340            UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 369

TABLE 341            FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     370

TABLE 342            FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   370

TABLE 343            FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            371

TABLE 344            FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)     371

TABLE 345            FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)       372

TABLE 346            FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            372

TABLE 347            FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            373

TABLE 348            FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       373

TABLE 349            FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 374

TABLE 350            FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            374

TABLE 351            FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 375

TABLE 352            FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 375

TABLE 353            FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 376

TABLE 354            FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 376

TABLE 355            FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            377

TABLE 356            FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                378

TABLE 357            FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 378

TABLE 358            FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            379

TABLE 359            FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              379

TABLE 360            FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            380

TABLE 361          FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            380

TABLE 362            FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 381

TABLE 363            FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)     381

TABLE 364            FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            382

TABLE 365            FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            382

TABLE 366            FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                383

TABLE 367            FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 383

TABLE 368            FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 384

TABLE 369            ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     385

TABLE 370            ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   385

TABLE 371            ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            386

TABLE 372            ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            386

TABLE 373            ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)              387

TABLE 374            ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            387

TABLE 375            ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            388

TABLE 376            ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       388

TABLE 377            ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 389

TABLE 378            ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            389

TABLE 379            ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 390

TABLE 380            ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 390

TABLE 381            ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 391

TABLE 382            ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 391

TABLE 383            ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            392

TABLE 384            ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)            393

TABLE 385            ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 393

TABLE 386            ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            394

TABLE 387            ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              394

TABLE 388            ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            395

TABLE 389            ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            395

TABLE 390            ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 396

TABLE 391            ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 396

TABLE 392            ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            397

TABLE 393            ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            397

TABLE 394            ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                398

TABLE 395            ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 398

TABLE 396            ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 399

TABLE 397            SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     400

TABLE 398            SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   400

TABLE 399            SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            401

TABLE 400            SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            401

TABLE 401            SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)              402

TABLE 402            SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            402

TABLE 403            SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            403

TABLE 404            SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       403

TABLE 405            SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 404

TABLE 406            SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            404

TABLE 407            SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 405

TABLE 408            SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 405

TABLE 409            SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 406

TABLE 410            SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 406

TABLE 411            SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            407

TABLE 412            SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)            408

TABLE 413            SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 408

TABLE 414            SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            409

TABLE 415            SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              409

TABLE 416            SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            410

TABLE 417            SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            410

TABLE 418            SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 411

TABLE 419            SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 411

TABLE 420            SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            412

TABLE 421            SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            412

TABLE 422            SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                413

TABLE 423            SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 413

TABLE 424            SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 414

TABLE 425            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)               415

TABLE 426            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)             415

TABLE 427            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            416

TABLE 428            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)  416

TABLE 429            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)   417

TABLE 430            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            417

TABLE 431            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            418

TABLE 432            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)            418

TABLE 433            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)       419

TABLE 434            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            419

TABLE 435            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 420

TABLE 436            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 420

TABLE 437            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            421

TABLE 438            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 421

TABLE 439            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)                422

TABLE 440            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)         423

TABLE 441            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)            423

TABLE 442            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            424

TABLE 443            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)       424

TABLE 444            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     425

TABLE 445            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)       425

TABLE 446            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 426

TABLE 447            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 426

TABLE 448            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 427

TABLE 449            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            427

TABLE 450            REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)               428

TABLE 451            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)            428

TABLE 452            REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 429

TABLE 453            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)     431

TABLE 454            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     432

TABLE 455            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   432

TABLE 456            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            433

TABLE 457            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            433

TABLE 458            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)             434

TABLE 459            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            434

TABLE 460            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            435

TABLE 461            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       435

TABLE 462            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 436

TABLE 463            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            436

TABLE 464            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 437

TABLE 465            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 437

TABLE 466            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 438

TABLE 467            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 438

TABLE 468            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            439

TABLE 469            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                440

TABLE 470            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 440

TABLE 471            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            441

TABLE 472            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              441

TABLE 473            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            442

TABLE 474            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)              442

TABLE 475            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 443

TABLE 476            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)     443

TABLE 477            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            444

TABLE 478            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            444

TABLE 479            ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)     445

TABLE 480            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 445

TABLE 481            ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 446

TABLE 482            CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     447

TABLE 483            CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   447

TABLE 484            CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            448

TABLE 485            CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)     448

TABLE 486            CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)       449

TABLE 487            CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            449

TABLE 488            CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            450

TABLE 489            CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       450

TABLE 490            CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 451

TABLE 491            CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            451

TABLE 492            CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 452

TABLE 493            CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 452

TABLE 494            CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 453

TABLE 495            CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 453

TABLE 496            CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            454

TABLE 497            CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)            455

TABLE 498            CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 455

TABLE 499            CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            456

TABLE 500            CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              456

TABLE 501            CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            457

TABLE 502            CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            457

TABLE 503            CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 458

TABLE 504            CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 458

TABLE 505            CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            459

TABLE 506            CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            459

TABLE 507            CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                460

TABLE 508            CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 460

TABLE 509            CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 461

TABLE 510            JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     462

TABLE 511            JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   462

TABLE 512            JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            463

TABLE 513            JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)     463

TABLE 514            JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)       464

TABLE 515            JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            464

TABLE 516            JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            465

TABLE 517            JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       465

TABLE 518            JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 466

TABLE 519            JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            466

TABLE 520            JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 467

TABLE 521            JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 467

TABLE 522            JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 468

TABLE 523            JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 468

TABLE 524            JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            469

TABLE 525            JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)            470

TABLE 526            JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 470

TABLE 527            JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            471

TABLE 528            JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              471

TABLE 529            JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            472

TABLE 530            JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            472

TABLE 531            JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 473

TABLE 532            JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 473

TABLE 533            JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            474

TABLE 534            JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            474

TABLE 535            JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                475

TABLE 536            JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 475

TABLE 537            JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 476

TABLE 538            INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     477

TABLE 539            INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   477

TABLE 540            INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            478

TABLE 541            INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)            478

TABLE 542            INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)              479

TABLE 543            INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            479

TABLE 544            INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            480

TABLE 545            INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       480

TABLE 546            INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 481

TABLE 547            INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            481

TABLE 548            INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 482

TABLE 549            INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 482

TABLE 550            INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 483

TABLE 551            INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 483

TABLE 552            INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            484

TABLE 553            INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)            485

TABLE 554            INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 485

TABLE 555            INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            486

TABLE 556            INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              486

TABLE 557            INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            487

TABLE 558            INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            487

TABLE 559            INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 488

TABLE 560            INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 488

TABLE 561            INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            489

TABLE 562            INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            489

TABLE 563            INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                490

TABLE 564            INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 490

TABLE 565            INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 491

TABLE 566            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)          492

TABLE 567            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)         492

TABLE 568            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)       493

TABLE 569            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)                 493

TABLE 570            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)                 494

TABLE 571            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)       494

TABLE 572            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 495

TABLE 573            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)         495

TABLE 574            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)                496

TABLE 575            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)       496

TABLE 576            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            497

TABLE 577            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)            497

TABLE 578            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                498

TABLE 579            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            498

TABLE 580            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)          499

TABLE 581            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                 500

TABLE 582            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 500

TABLE 583            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)       501

TABLE 584            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)   501

TABLE 585            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)                 502

TABLE 586            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)   502

TABLE 587            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)            503

TABLE 588            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)            503

TABLE 589            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            504

TABLE 590            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)       504

TABLE 591            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)           505

TABLE 592            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 505

TABLE 593            REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            506

TABLE 594            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION)               507

TABLE 595            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)               508

TABLE 596            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)             508

TABLE 597            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            509

TABLE 598            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)  509

TABLE 599            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)   510

TABLE 600            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            510

TABLE 601            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            511

TABLE 602            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)            511

TABLE 603            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)       512

TABLE 604            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            512

TABLE 605            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 513

TABLE 606            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 513

TABLE 607            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            514

TABLE 608            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 514

TABLE 609            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)                515

TABLE 610            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)         516

TABLE 611            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)            516

TABLE 612            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            517

TABLE 613            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)       518

TABLE 614            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     518

TABLE 615            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)       519

TABLE 616            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 519

TABLE 617            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 520

TABLE 618            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 520

TABLE 619            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            521

TABLE 620            LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)               521

TABLE 621            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)            522

TABLE 622            LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 522

TABLE 623            BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     523

TABLE 624            BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   524

TABLE 625            BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            524

TABLE 626            BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)     525

TABLE 627            BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)       525

TABLE 628            BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            526

TABLE 629            BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            526

TABLE 630            BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       527

TABLE 631            BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 527

TABLE 632            BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            528

TABLE 633            BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 528

TABLE 634            BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 529

TABLE 635            BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 529

TABLE 636            BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 530

TABLE 637            BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            530

TABLE 638            BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                531

TABLE 639            BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 531

TABLE 640            BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            532

TABLE 641            BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              532

TABLE 642            BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            533

TABLE 643            BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            533

TABLE 644            BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 534

TABLE 645            BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION) 534

TABLE 646            BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            535

TABLE 647            BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            535

TABLE 648            BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                536

TABLE 649            BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 536

TABLE 650            BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 537

TABLE 651            MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)     538

TABLE 652            MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)   538

TABLE 653            MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            539

TABLE 654            MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)     539

TABLE 655            MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)       540

TABLE 656            MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            540

TABLE 657            MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            541

TABLE 658            MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)       541

TABLE 659            MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 542

TABLE 660            MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            542

TABLE 661            MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 543

TABLE 662            MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 543

TABLE 663            MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION) 544

TABLE 664            MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 544

TABLE 665            MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)            545

TABLE 666            MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                546

TABLE 667            MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                 546

TABLE 668            MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            547

TABLE 669            MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)              547

TABLE 670            MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            548

TABLE 671          MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)            548

TABLE 672            MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 549

TABLE 673            MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)     549

TABLE 674            MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            550

TABLE 675            MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            550

TABLE 676            MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)                551

TABLE 677            MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                 551

TABLE 678            MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE 2022–2030 (USD MILLION)                 552

TABLE 679            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)          553

TABLE 680            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)         553

TABLE 681            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)       554

TABLE 682            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)                 554

TABLE 683            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)                 555

TABLE 684            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)       555

TABLE 685            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 556

TABLE 686            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)         556

TABLE 687            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)                557

TABLE 688            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)       557

TABLE 689            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            558

TABLE 690            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)            558

TABLE 691            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                559

TABLE 692            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            559

TABLE 693            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)          560

TABLE 694            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                 561

TABLE 695            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 561

TABLE 696            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)       562

TABLE 697            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)   562

TABLE 698            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)                 563

TABLE 699            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)   563

TABLE 700            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)            564

TABLE 701            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)            564

TABLE 702            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            565

TABLE 703            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)       565

TABLE 704            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)           566

TABLE 705            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 566

TABLE 706            REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            567

TABLE 707            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION)                569

TABLE 708            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)          569

TABLE 709            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)         570

TABLE 710            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)       570

TABLE 711            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)                 571

TABLE 712            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)                 571

TABLE 713            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)       572

TABLE 714            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION) 572

TABLE 715            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)         573

TABLE 716            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)                573

TABLE 717            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)       574

TABLE 718            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            574

TABLE 719            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)            575

TABLE 720            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                575

TABLE 721            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            576

TABLE 722            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)          576

TABLE 723            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                 577

TABLE 724            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION) 577

TABLE 725            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)       578

TABLE 726            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)   578

TABLE 727            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)                 579

TABLE 728            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)   579

TABLE 729            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)            580

TABLE 730            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)            580

TABLE 731            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            581

TABLE 732            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)       581

TABLE 733            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)           582

TABLE 734            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 582

TABLE 735            MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            583

TABLE 736            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)               584

TABLE 737            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)             584

TABLE 738            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)            585

TABLE 739            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION)  585

TABLE 740            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION)   586

TABLE 741            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)            586

TABLE 742            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)            587

TABLE 743            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)            587

TABLE 744            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION)       588

TABLE 745            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            588

TABLE 746            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 589

TABLE 747            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)                 589

TABLE 748            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)            590

TABLE 749            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)                 590

TABLE 750            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)                591

TABLE 751            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)         592

TABLE 752            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)            592

TABLE 753            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)            593

TABLE 754            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)       593

TABLE 755            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)     594

TABLE 756            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)       594

TABLE 757            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 595

TABLE 758            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)                 595

TABLE 759            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION) 596

TABLE 760            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)            596

TABLE 761            GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)               597

TABLE 762            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)            597

TABLE 763            GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)                 598

TABLE 764            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2022–2030 (USD MILLION)            599

TABLE 765            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2022–2030 (USD MILLION)            599

TABLE 766            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2022–2030 (USD MILLION)         600

TABLE 767            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2022–2030 (USD MILLION) 600

TABLE 768            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2022–2030 (USD MILLION) 601

TABLE 769            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2022–2030 (USD MILLION)              601

TABLE 770            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2022–2030 (USD MILLION)   602

TABLE 771            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2022–2030 (USD MILLION)                 602

TABLE 772            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2022–2030 (USD MILLION) 603

TABLE 773            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)                603

TABLE 774            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2022–2030 (USD MILLION)            604

TABLE 775            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2022–2030 (USD MILLION)            604

TABLE 776            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)  605

TABLE 777            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2022–2030 (USD MILLION)       605

TABLE 778            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2022–2030 (USD MILLION)                 606

TABLE 779            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2022–2030 (USD MILLION)                 607

TABLE 780            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2022–2030 (USD MILLION)                607

TABLE 781            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE FUNCTIONS, BY TYPE, 2022–2030 (USD MILLION)                608

TABLE 782            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2022–2030 (USD MILLION)            609

TABLE 783            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 609

TABLE 784            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2022–2030 (USD MILLION)                 610

TABLE 785            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2022–2030 (USD MILLION)            610

TABLE 786            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2022–2030 (USD MILLION)       611

TABLE 787            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2022–2030 (USD MILLION)            611

TABLE 788            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2022–2030 (USD MILLION)                612

TABLE 789            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2022–2030 (USD MILLION)            612

TABLE 790            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                613

TABLE 791            REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2022–2030 (USD MILLION)            613

TABLE 792            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2021–NOVEMBER 2024               614

TABLE 793            ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET SHARE ANALYSIS, 2023                 619

TABLE 794            AI IN HEALTHCARE MARKET: REGION FOOTPRINT       624

TABLE 795            AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT       625

TABLE 796            AI IN HEALTHCARE MARKET: TOOL FOOTPRINT       626

TABLE 797            AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT       627

TABLE 798            AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT       628

TABLE 799            AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT       629

TABLE 800            AI IN HEALTHCARE MARKET: END-USER FOOTPRINT       630

TABLE 801            AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS               633

TABLE 802            AI IN HEALTHCARE MARKET: REGION FOOTPRINT (STARTUPS/SMES)                 633

TABLE 803            AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES,

JANUARY 2021–NOVEMBER 2024                 636

TABLE 804            AI IN HEALTHCARE MARKET: DEALS, JANUARY 2021–NOVEMBER 2024    637

TABLE 805            AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–NOVEMBER 2024                 638

TABLE 806            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          640

TABLE 807            KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED        641

TABLE 808            KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES,

JANUARY 2021–NOVEMBER 2024                 644

TABLE 809            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–NOVEMBER 2024    645

TABLE 810            KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024                 646

TABLE 811            KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS,

JANUARY 2021–NOVEMBER 2024                 646

TABLE 812            MICROSOFT CORPORATION: COMPANY OVERVIEW          648

TABLE 813            MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED        650

TABLE 814            MICROSOFT CORPORATION: PRODUCT LAUNCHES,

JANUARY 2021–NOVEMBER 2024                 651

TABLE 815            MICROSOFT CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024    652

TABLE 816            NVIDIA CORPORATION: COMPANY OVERVIEW                 656

TABLE 817            NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED             657

TABLE 818            NVIDIA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024                 658

TABLE 819            NVIDIA CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024               659

TABLE 820            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          661

TABLE 821            SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED        663

TABLE 822            SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2021–NOVEMBER 2024                 664

TABLE 823            SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–NOVEMBER 2024    664

TABLE 824            SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024            665

TABLE 825            GE HEALTHCARE: COMPANY OVERVIEW                 667

TABLE 826            GE HEALTHCARE: PRODUCTS & SERVICES OFFERED             669

TABLE 827            GE HEALTHCARE: DEALS, JANUARY 2021–NOVEMBER 2024               670

TABLE 828            EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW          672

TABLE 829            EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED        672

TABLE 830            EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024                 673

TABLE 831            ORACLE: COMPANY OVERVIEW                674

TABLE 832            ORACLE: PRODUCTS & SERVICES OFFERED                 676

TABLE 833            ORACLE: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024       677

TABLE 834            ORACLE: DEALS, JANUARY 2021–MARCH 2024                 677

TABLE 835            VERADIGM LLC: COMPANY OVERVIEW 679

TABLE 836            VERADIGM LLC: PRODUCTS & SERVICES OFFERED             680

TABLE 837            VERADIGM LLC: DEALS, JANUARY 2021–MARCH 2024        681

TABLE 838            AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW          682

TABLE 839            AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED        683

TABLE 840            AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES,

JANUARY 2021–MARCH 2024         684

TABLE 841            AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2021–MARCH 2024             685

TABLE 842            IBM: COMPANY OVERVIEW         686

TABLE 843            MERATIVE: PRODUCTS & SERVICES OFFERED                 687

TABLE 844            MERATIVE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024    688

TABLE 845            MERATIVE: DEALS, JANUARY 2021–NOVEMBER 2024        689

TABLE 846            MEDTRONIC: COMPANY OVERVIEW       690

TABLE 847            MEDTRONIC: PRODUCTS & SERVICES OFFERED                 691

TABLE 848            MEDTRONIC: DEALS, JANUARY 2021–NOVEMBER 2024               692

TABLE 849            GOOGLE: COMPANY OVERVIEW               693

TABLE 850            GOOGLE: PRODUCTS & SERVICES OFFERED                 694

TABLE 851            GOOGLE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024    695

TABLE 852            GOOGLE: DEALS, JANUARY 2021–NOVEMBER 2024        696

TABLE 853            GOOGLE: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024    697

TABLE 854            SOPHIA GENETICS: COMPANY OVERVIEW                 698

TABLE 855            SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED             699

TABLE 856            SOPHIA GENETICS: DEALS, JANUARY 2021–NOVEMBER 2024               699

TABLE 857            JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW   700

TABLE 858            JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED            701

TABLE 859            JOHNSON & JOHNSON SERVICES, INC.: DEALS, JANUARY 2021–NOVEMBER 2024                 702

TABLE 860            TEMPUS: COMPANY OVERVIEW                703

TABLE 861            TEMPUS: PRODUCTS & SERVICES OFFERED                 704

TABLE 862            TEMPUS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–NOVEMBER 2024                 705

TABLE 863            TEMPUS: DEALS, JANUARY 2021–NOVEMBER 2024        705

TABLE 864            CONCERTAI: COMPANY OVERVIEW        706

TABLE 865            CONCERTAI: PRODUCTS & SERVICES OFFERED                 706

TABLE 866            CONCERTAI: PRODUCT LAUNCHES & UPGRADES,

JANUARY 2021–NOVEMBER 2024                 707

TABLE 867            CONCERTAI: DEALS, JANUARY 2021–MARCH 2024        708

TABLE 868            3M: COMPANY OVERVIEW           709

TABLE 869            3M: PRODUCTS & SERVICES OFFERED   710

TABLE 870            3M: DEALS, JANUARY 2021–NOVEMBER 2024                 710

TABLE 871            COGNIZANT: COMPANY OVERVIEW       711

TABLE 872            COGNIZANT: PRODUCTS & SERVICES OFFERED                 712

TABLE 873            COGNIZANT: PRODUCT LAUNCHES & UPGRADES,

JANUARY 2021–NOVEMBER 2024                 713

TABLE 874            COGNIZANT: DEALS, JANUARY 2021–NOVEMBER 2024               714

TABLE 875            VIZ.AI, INC.: COMPANY OVERVIEW          715

TABLE 876            VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED                 715

TABLE 877            VIZ.AI, INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024    716

TABLE 878            VIZ.AI, INC.: DEALS, JANUARY 2021–NOVEMBER 2024        716

TABLE 879            VIZ.AI, INC.: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2024    718

TABLE 880            RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW          719

TABLE 881            RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED        719

TABLE 882            RIVERAIN TECHNOLOGIES: DEALS, JANUARY 2021–NOVEMBER 2024    720

LIST OF FIGURES

FIGURE 1              AI IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE            58

FIGURE 2              RESEARCH DESIGN         65

FIGURE 3              PRIMARY SOURCES         68

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                69

FIGURE 5              MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS            70

FIGURE 6              BOTTOM-UP APPROACH: END-USER SPENDING ON AI IN HEALTHCARE 71

FIGURE 7              AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030)              73

FIGURE 8              CAGR PROJECTION: SUPPLY-SIDE ANALYSIS                 74

FIGURE 9              TOP-DOWN APPROACH                74

FIGURE 10            DATA TRIANGULATION METHODOLOGY                 76

FIGURE 11            AI IN HEALTHCARE MARKET, BY OFFERING, 2024 VS. 2030 (USD MILLION)      79

FIGURE 12            AI IN HEALTHCARE MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION)      80

FIGURE 13            AI IN HEALTHCARE MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION)      81

FIGURE 14            AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,

2024 VS. 2030 (USD MILLION)      81

FIGURE 15            AI IN HEALTHCARE MARKET, BY TOOL, 2024 VS. 2030 (USD MILLION)       82

FIGURE 16            AI IN HEALTHCARE MARKET, BY END USER, 2024 VS. 2030 (USD MILLION)                83

FIGURE 17            AI IN HEALTHCARE MARKET: REGIONS COVERED            84

FIGURE 18            RISING NEED FOR EARLY DISEASE DETECTION TO DRIVE MARKET         85

FIGURE 19            JAPAN TO DOMINATE MARKET IN ASIA PACIFIC IN 2024  86

FIGURE 20            INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       87

FIGURE 21            NORTH AMERICA TO DOMINATE AI IN HEALTHCARE MARKET DURING FORECAST PERIOD      87

FIGURE 22            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    88

FIGURE 23            AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         89

FIGURE 24            DATA BREACHES IN HEALTHCARE SECTOR, 2019–2023              99

FIGURE 25            CHALLENGES ASSOCIATED WITH HEALTHCARE DATA INTEROPERABILITY          100

FIGURE 26            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           101

FIGURE 27            AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS            107

FIGURE 28            AI IN HEALTHCARE MARKET: ECOSYSTEM MAPPING             109

FIGURE 29            AI IN HEALTHCARE MARKET: PATENTS GRANTED, 2013–2023      115

FIGURE 30            AI IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS           128

FIGURE 31            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 130

FIGURE 32            KEY BUYING CRITERIA FOR TOP THREE END USERS   131

FIGURE 33            AI IN HEALTHCARE MARKET: INVESTMENT & FUNDING SCENARIO, 2024            135

FIGURE 34            GEN AI USE CASES IN HEALTHCARE        137

FIGURE 35            NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT          276

FIGURE 36            EUROPE: AI IN HEALTHCARE MARKET SNAPSHOT          323

FIGURE 37            ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT          430

FIGURE 38            REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2019–2023            618

FIGURE 39            MARKET SHARE ANALYSIS OF KEY PLAYERS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2023                 619

FIGURE 40            RANKING OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2023      621

FIGURE 41            AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023         622

FIGURE 42            AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT       623

FIGURE 43            AI IN HEALTHCARE MARKET:

COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 632

FIGURE 44            EV/EBITDA OF KEY VENDORS   634

FIGURE 45            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS      634

FIGURE 46            AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     635

FIGURE 47            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)             641

FIGURE 48            MICROSOFT CORPORATION: COMPANY SNAPSHOT (2023)             649

FIGURE 49            NVIDIA CORPORATION: COMPANY SNAPSHOT (2023)    657

FIGURE 50            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)             662

FIGURE 51            GE HEALTHCARE: COMPANY SNAPSHOT (2023)                 668

FIGURE 52            ORACLE: COMPANY SNAPSHOT (2023)   675

FIGURE 53            VERADIGM LLC: COMPANY SNAPSHOT (2021)                 680

FIGURE 54            AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2023)             683

FIGURE 55            IBM: COMPANY SNAPSHOT (2023)            687

FIGURE 56            MEDTRONIC: COMPANY SNAPSHOT (2023)                 691

FIGURE 57            GOOGLE: COMPANY SNAPSHOT (2023) 694

FIGURE 58            SOPHIA GENETICS: COMPANY SNAPSHOT (2023)    698

FIGURE 59            JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)      701

FIGURE 60            3M: COMPANY SNAPSHOT (2023)              709

FIGURE 61            COGNIZANT: COMPANY SNAPSHOT (2023)                 712


    주문/문의폼

    • 리포트 제목은 자동으로 입력됩니다.

    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com